These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3065054)

  • 21. [Use of sulbactam/ampicillin in the treatment of infections at various sites].
    Migliorato D; Consolo A; Migliorato A; Leone E; Canale MP
    G Ital Chemioter; 1987; 34(1-3):47-55. PubMed ID: 3504414
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical evaluation of sultamicillin in lower respiratory tract infections].
    Ishibashi T; Takamoto M; Shinoda A; Yoshida M; Ichikawa Y; Kido M; Ninomiya K; Kitahara Y; Miyazaki N; Matsuzaki Y
    Jpn J Antibiot; 1991 Feb; 44(2):150-9. PubMed ID: 2041156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of sulbactam/ampicillin and sultamicillin in the treatment of bacterial infections of the upper respiratory tract of children.
    Bluestone CD
    APMIS Suppl; 1989; 5():35-40. PubMed ID: 2660869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sultamicillin experiences in the field of internal medicine.
    Hara K; Kobayashi H
    APMIS Suppl; 1989; 5():51-6. PubMed ID: 2660872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of ampicillin/sulbactam and cefuroxime in the treatment of serious skin and skin structure infections in pediatric patients. UNASYN Pediatric Study Group.
    Azimi PH; Barson WJ; Janner D; Swanson R
    Pediatr Infect Dis J; 1999 Jul; 18(7):609-13. PubMed ID: 10440436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sulbactam/ampicillin versus cefoxitin for uncomplicated and complicated acute pelvic inflammatory disease.
    Hemsell DL; Heard MC; Hemsell PG; Nobles BJ
    Drugs; 1988; 35 Suppl 7():39-42. PubMed ID: 3220008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Worldwide clinical experience with sultamicillin.
    Pitts NE; Gilbert GS; Knirsch AK; Noguchi Y
    APMIS Suppl; 1989; 5():23-34. PubMed ID: 2660868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pharmacokinetic, bacteriological and clinical studies of sulbactam/ampicillin in pediatric patients].
    Motohiro T; Sakata Y; Oda K; Aramaki M; Tanaka K; Koga T; Shimada Y; Fujimoto T; Yamashita F; Sakamoto H
    Jpn J Antibiot; 1989 Mar; 42(3):773-90. PubMed ID: 2664252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sultamicillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Friedel HA; Campoli-Richards DM; Goa KL
    Drugs; 1989 Apr; 37(4):491-522. PubMed ID: 2661196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concentrations of sulbactam/ampicillin in serum and lung tissue.
    Frank U; Schmidt-Eisenlohr E; Joos-Württemberger A; Hasse J; Daschner F
    Infection; 1990; 18(5):307-9. PubMed ID: 2276827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of sulbactam-ampicillin in the treatment of neonatal calf diarrhoea.
    Grimshaw WT; Colman PJ; Petrie L
    Vet Rec; 1987 Aug; 121(8):162-6. PubMed ID: 3660556
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical studies on sulbactam/ampicillin in the field of pediatrics].
    Iwata S; Yamada K; Sato Y; Ishikawa K; Akita H; Sunakawa K
    Jpn J Antibiot; 1989 Mar; 42(3):598-611. PubMed ID: 2664249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Sulacillin (a combination of ampicillin and sulbactam)--a new combined drug form for treatment of bacterial infections].
    Bogomolova NS; Belova ON; Vasil'ev MM; Novikova IuA; Pankova GF; Perepanova TS; Sokolova VI; Strachunskiĭ LS; Shandurenko IN; Pozdniakova VP
    Antibiot Khimioter; 1995 Jun; 40(6):43-8. PubMed ID: 8593095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rational antibiotic therapy and the position of ampicillin/sulbactam.
    Lode HM
    Int J Antimicrob Agents; 2008 Jul; 32(1):10-28. PubMed ID: 18539004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of a beta-lactamase inhibitor combination for serious intraabdominal infections.
    Walker AP; Nichols RL; Wilson RF; Bivens BA; Trunkey DD; Edmiston CE; Smith JW; Condon RE
    Ann Surg; 1993 Feb; 217(2):115-21. PubMed ID: 8439209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sulbactam: a beta-lactamase inhibitor.
    Noguchi JK; Gill MA
    Clin Pharm; 1988 Jan; 7(1):37-51. PubMed ID: 3278833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical evaluation of sulbactam/cefoperazone in lower respiratory tract infections].
    Ishibashi T; Takamoto M; Shinoda A; Yoshida M; Ichikawa Y; Kido M; Ninomiya K; Kitahara Y; Hara N; Tsurutani H
    Jpn J Antibiot; 1990 Feb; 43(2):239-56. PubMed ID: 2194054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and cost of ampicillin-sulbactam and ticarcillin-clavulanate in the treatment of hospitalized patients with bacterial infections.
    McKinnon PS; Neuhauser MM
    Pharmacotherapy; 1999 Jun; 19(6):724-33. PubMed ID: 10391418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical evaluation of sulbactam plus ampicillin in the treatment of general pediatric infections.
    Bassetti D; Solbiati M; Ravelli A; Martini A; Viola S; Burgio RG
    APMIS Suppl; 1989; 5():41-4. PubMed ID: 2660870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experience with ampicillin/sulbactam in severe infections.
    Kanra G
    J Int Med Res; 2002; 30 Suppl 1():20A-30A. PubMed ID: 11921491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.